JPRN-UMIN000009263已完成未知
Prospective study of Docetaxel combined with Bevacizumab in advanced or recurrent non-squamous non-small cell lung cancer patients unfit for platinum-doublet chemotherapy and exploratory biomarker analysis for predicting the effect with antiangiogenic therapy.(OLCAS-001) - Phase II study of Docetaxel plus Bevacizumab in non-squamous NSCLC patients unfit for platinum-doublet chemotherapy
Oita University Faculty of Medicine, Department of Medical Oncology & Hematology0 个研究点目标入组 40 人开始时间: 2012年11月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) with uncontrollable co-morbidities 2)with episode of hemoptysis 3)clinically unfit for bevacizumab containing chemotherapy 4)with severe allergy of the medication 5)with ineligible conditions judged by the attending physician
研究者
相似试验
已完成
2 期
Phase II Study of Docetaxel+Bevacizumab with non-squamous non-small cell lung cancer for patients pretreated with chemotherapyon-small-cell lung cancerJPRN-UMIN000005077Tochigi Cancer Center22
已完成
2 期
Randomised Phase II study of combined Docetaxel and Nedaplatin versus Docetaxel alone chemotherapy in advanced or recurrent esophageal cancerAdvanced or recurrent esophageal cancerJPRN-UMIN000005877Toho University43
已完成
2 期
A phase II study of Docetaxel with Bevacizumab for EGFR mutation negative previously treated non-squamous non-small cell lung canceron-Squamous Non-Small Cell Lung CancerJPRN-UMIN000006532ihon University School of Medicine30
已完成
不适用
A phase II study of Docetaxel with Bevacizumab for previously treated non-squamous non-small cell lung cancer.non-squamous non-small cell lung cancer.JPRN-UMIN000008687First Department of Internal Medicine,25
已完成
1 期
Phase I/II study of Docetaxel with Bevacizumab for refractory and geriatric non-squamous non-small cell lung canceron-Squamous Non-Small Cell Lung CancerJPRN-UMIN000006152Chiba Tokushukai Hospital20